PortfoliosLab logoPortfoliosLab logo
ASPN vs. TWST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASPN vs. TWST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aspen Aerogels, Inc. (ASPN) and Twist Bioscience Corporation (TWST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASPN achieves a 108.48% return, which is significantly lower than TWST's 128.03% return.


ASPN

1D
-5.14%
1M
52.06%
YTD
108.48%
6M
69.54%
1Y
1.03%
3Y*
-6.59%
5Y*
-23.03%
10Y*
3.66%

TWST

1D
3.11%
1M
28.72%
YTD
128.03%
6M
132.05%
1Y
134.23%
3Y*
64.29%
5Y*
-5.57%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASPN vs. TWST - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ASPN
Aspen Aerogels, Inc.
108.48%-76.18%-24.71%33.84%-76.32%198.32%115.08%264.32%-40.50%
TWST
Twist Bioscience Corporation
128.03%-31.74%26.07%54.81%-69.23%-45.23%572.81%-9.05%64.93%

Correlation

The correlation between ASPN and TWST is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.36

Correlation (5Y)
Calculated over the trailing 5-year period

0.41

Correlation (All Time)
Calculated using the full available price history since Nov 1, 2018

0.34

The correlation between ASPN and TWST shifts across timeframes, from 0.30 (1 year) to 0.41 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ASPN:

$488.18M

TWST:

$4.46B

EPS

ASPN:

-$1.36

TWST:

-$1.33

PS Ratio

ASPN:

2.11

TWST:

10.79

PB Ratio

ASPN:

2.29

TWST:

9.81

Total Revenue (TTM)

ASPN:

$230.26M

TWST:

$409.48M

Gross Profit (TTM)

ASPN:

$27.46M

TWST:

$213.23M

EBITDA (TTM)

ASPN:

-$59.70M

TWST:

-$58.23M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASPN vs. TWST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASPN
ASPN Risk / Return Rank: 4343
Overall Rank
ASPN Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
ASPN Sortino Ratio Rank: 4747
Sortino Ratio Rank
ASPN Omega Ratio Rank: 5050
Omega Ratio Rank
ASPN Calmar Ratio Rank: 4040
Calmar Ratio Rank
ASPN Martin Ratio Rank: 4040
Martin Ratio Rank

TWST
TWST Risk / Return Rank: 8383
Overall Rank
TWST Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
TWST Sortino Ratio Rank: 8484
Sortino Ratio Rank
TWST Omega Ratio Rank: 7979
Omega Ratio Rank
TWST Calmar Ratio Rank: 8585
Calmar Ratio Rank
TWST Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASPN vs. TWST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aspen Aerogels, Inc. (ASPN) and Twist Bioscience Corporation (TWST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ASPNTWSTDifference

Sharpe ratio

Return per unit of total volatility

0.01

2.04

-2.03

Sortino ratio

Return per unit of downside risk

0.71

2.63

-1.92

Omega ratio

Gain probability vs. loss probability

1.11

1.30

-0.19

Calmar ratio

Return relative to maximum drawdown

0.01

3.53

-3.52

Martin ratio

Return relative to average drawdown

0.02

7.49

-7.47

ASPN vs. TWST - Sharpe Ratio Comparison

The current ASPN Sharpe Ratio is 0.01, which is lower than the TWST Sharpe Ratio of 2.04. The chart below compares the historical Sharpe Ratios of ASPN and TWST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ASPNTWSTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.01

2.04

-2.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.26

-0.07

-0.19

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.05

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.31

-0.38

Drawdowns

ASPN vs. TWST - Drawdown Comparison

The maximum ASPN drawdown since its inception was -95.96%, roughly equal to the maximum TWST drawdown of -94.48%. Use the drawdown chart below to compare losses from any high point for ASPN and TWST.


Loading charts...

Drawdown Indicators


ASPNTWSTDifference

Max Drawdown

Largest peak-to-trough decline

-95.96%

-94.48%

-1.48%

Max Drawdown (1Y)

Largest decline over 1 year

-70.86%

-38.24%

-32.62%

Max Drawdown (3Y)

Largest decline over 3 years

-91.90%

-58.97%

-32.93%

Max Drawdown (5Y)

Largest decline over 5 years

-95.96%

-91.54%

-4.42%

Max Drawdown (10Y)

Largest decline over 10 years

-95.96%

Current Drawdown

Current decline from peak

-90.73%

-65.22%

-25.51%

Average Drawdown

Average peak-to-trough decline

-56.38%

-58.15%

+1.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

45.10%

17.98%

+27.12%

Volatility

ASPN vs. TWST - Volatility Comparison

Aspen Aerogels, Inc. (ASPN) has a higher volatility of 28.43% compared to Twist Bioscience Corporation (TWST) at 19.75%. This indicates that ASPN's price experiences larger fluctuations and is considered to be riskier than TWST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASPNTWSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.43%

19.75%

+8.68%

Volatility (6M)

Calculated over the trailing 6-month period

65.20%

47.14%

+18.06%

Volatility (1Y)

Calculated over the trailing 1-year period

91.98%

66.14%

+25.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.84%

75.77%

+12.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.23%

78.41%

-3.18%

Dividends

ASPN vs. TWST - Dividend Comparison

Neither ASPN nor TWST has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ASPN vs. TWST - Financials Comparison

This section allows you to compare key financial metrics between Aspen Aerogels, Inc. and Twist Bioscience Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00M120.00M20222023202420252026
37.88M
110.72M
(ASPN) Total Revenue
(TWST) Total Revenue
Values in USD except per share items

ASPN vs. TWST - Profitability Comparison

The chart below illustrates the profitability comparison between Aspen Aerogels, Inc. and Twist Bioscience Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-60.0%-40.0%-20.0%0.0%20.0%40.0%60.0%20222023202420252026
11.3%
51.6%
Portfolio components
ASPN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported a gross profit of 4.28M and revenue of 37.88M. Therefore, the gross margin over that period was 11.3%.

TWST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Twist Bioscience Corporation reported a gross profit of 57.12M and revenue of 110.72M. Therefore, the gross margin over that period was 51.6%.

ASPN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported an operating income of -20.83M and revenue of 37.88M, resulting in an operating margin of -55.0%.

TWST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Twist Bioscience Corporation reported an operating income of -45.86M and revenue of 110.72M, resulting in an operating margin of -41.4%.

ASPN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported a net income of -23.69M and revenue of 37.88M, resulting in a net margin of -62.5%.

TWST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Twist Bioscience Corporation reported a net income of -44.02M and revenue of 110.72M, resulting in a net margin of -39.8%.


Frequently Asked Questions


ASPN and TWST have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASPN has higher volatility (28.43%) compared to TWST (19.75%). In terms of maximum drawdown, ASPN dropped -95.96% vs TWST's -94.48%.

TWST currently has the higher Sharpe Ratio (2.04 vs 0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASPN and TWST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer